Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | GP795 | — |
Pediatric dose to an adult patient; Pediatric dose to an adult patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 71-year-old female patient who received HAV (Havrix pediatric) (batch number GP795) for prophylaxis. On 23-FEB-2026, the patient received Havrix pediatric. On 23-FEB-2026, an unknown time after receiving Havrix pediatric, the patient experienced adult use of a child product (Verbatim: Pediatric dose to an adult patient) and underdose (Verbatim: Pediatric dose to an adult patient). The outcome of the adult use of a child product and underdose were not applicable.